Disc Medicine's stock fell 22% after the FDA issued a Complete Response Letter rejecting its new drug application due to uncertainties requiring more evidence. The Rosen Law Firm is investigating potential securities claims and preparing a class action for investors who purchased Disc Medicine securities, offering compensation without upfront fees. Investors can join the class action through the firm's website or contact details provided. This legal action highlights risks related to regulatory setbacks impacting stock prices.
Disc Medicine's recent legal investigation news is contextually noted alongside Pluang's health sector data. For readers following health stocks, here is Pluang's market snapshot as of Sep 22, 2026 03:42 WIB: Among 94 priced health-sector US stocks, 56 rose and 38 fell. Notable movers include HIMS at USD 29.28 (+4.61%), ADMA at USD 9.51 (+4.39%), and ACB at USD 4.04 (+4.26%).
Priority Technology Holdings is being taken private in a $1.6 billion deal led by its Chairman and CEO, Thomas Priore. The acquisition price is $8.05 per share, matching the analyst price target set by Lake Street, which downgraded the stock to 'Hold...
General Mills is set to report its Q3 2026 earnings with an expected 16.3% decline in earnings per share to $0.72 and revenue forecast around $4.35 billion, down from last year. Despite these declines, the company reaffirmed its full-year adjusted EP...
Boeing is experiencing ongoing production challenges with its 737 MAX aircraft, causing delays and a recent 3.7% stock drop. Jefferies lowered its price target to $265, still implying a 32% upside from current prices, reflecting cautious optimism. Ba...
ALUULA Composites has signed a staged funding agreement under Canada's Industrial and Technological Benefits (ITB) Policy, securing $730,000 CAD for research and development. The funding is shared equally between ALUULA and IBERCISA Deck Machinery, l...
Summit Royalties Ltd. plans to expand its producing portfolio from four to six assets by 2027, with gold equivalent ounces expected to more than double in 2027 and again in 2028. The company benefits from a $50 million credit facility from National B...
